Persistent pulmonary hypertension of the newborn (PPHN) is associated with chronic intrauterine events. Acute nitric oxide (NO) inhibition attenuates the normal increase in pulmonary blood flow at birth. We investigated whether chronic NO inhibition in utero causes persistent pulmonary hypertension. 11 fetal lambs received either a continuous infusion of Nw-nitro-L-arginine (an NO synthesis inhibitor) or 0.9% saline. Before infusion, acetylcholine (dependent upon endogenous NO production) and sodium nitroprusside (which releases its own NO) produced potent pulmonary vasodilation. After 10.5±1.5 d of infusion, acetylcholine did not produce pulmonary vasodilation in N'-nitro-L-arginine-treated fetal lambs, but did in salinetreated fetal lambs; sodium nitroprusside produced pulmonary vasodilation in both groups. Immediately after birth, at 140 d of gestation, during the 3-h study period, mean pulmonary arterial pressure did not decrease in Nw-nitro-L-arginine-treated lambs; the increase in pulmonary blood flow and decrease in pulmonary vascular resistance were markedly attenuated compared to saline-treated lambs. These hemodynamic derangements were reversed by L-arginine. There were no anatomic abnormalities in the pulmonary circulation. Chronic NO inhibition in utero reproduces many of the physiologic derangements of PPHN. Intrauterine events which result in endothelial dysfunction and inhibition of NO may produce the physiologic derrangements of PPHN. (J. Clin. Invest. 1994. 93:2675-2683
Introduction
With the onset of ventilation at birth, pulmonary arterial pressure and pulmonary vascular resistance decrease rapidly, and pulmonary blood flow increases 8-to 10-fold (1, 2) . Although the mechanisms of these circulatory changes are not completely understood, the creation of an air-fluid interface, increased oxygen tension, rhythmic distension of the lungs, and the release of vasoactive substances all have important roles in this transition (2) (3) (4) (5) (6) (7) .
The clinical syndrome of persistent pulmonary hypertension of the newborn (PPHN)' is characterized by failure of the pulmonary circulation to undergo the normal transition from fetal to postnatal life. PPHN results in maintenance of high pulmonary vascular resistance, low pulmonary blood flow, and persistence of right-to-left shunting of blood through the foramen ovale and/or the ductus arteriosus. The syndrome is associated with a variety of conditions, including asphyxia, sepsis, and meconium aspiration; however, the etiology remains unknown (8, 9) .
Recent reports indicate that exogenous inhaled nitric oxide (NO) produces potent and selective pulmonary vasodilation in some newborns with PPHN (10, 1 1) . NO is endogenously synthesized by the vascular endothelium from L-arginine. It is an important mediator ofresting pulmonary vascular tone in both the fetus and newborn (12) (13) (14) (15) (16) . Once synthesized and released, NO diffuses into vascular smooth muscle cells where it activates soluble guanylate cyclase, the enzyme that catalyzes the production of cGMP from guanosine 5'-triphosphate. Activation ofguanylate cyclase increases the concentration ofcGMP, thus initiating a cascade that results in smooth muscle relaxation (17) . In addition to its vasodilating activity, NO inhibits platelet aggregation and smooth muscle cell proliferation (18, 19) . In animals, acute inhibition ofNO synthesis attenuates the normal increase in pulmonary blood flow at birth, suggesting that NO activity is stimulated and may contribute to the decrease in pulmonary vascular resistance at birth (15, 16, 20) . However, acute inhibition ofNO synthesis does not mimic the clinical syndrome of PPHN, because pulmonary arterial pressure still decreases normally (15) . Therefore, the role of NO activity in the normal transition at birth and in the pathophysiology of PPHN remains unclear.
Several clinical and experimental observations suggest that intrauterine events may be related to the development of PPHN. For example, infants who die of PPHN often have marked pulmonary vascular structural changes, suggestive ofa chronic intrauterine event (21, 22) . In addition, in animal models, it requires chronic constriction or ligation of the ductus arteriosus to reproduce the physiologic and pathologic derangements of PPHN (23) (24) (25) (26) . The purpose ofthe present study was to determine the physiologic and pathologic derangements induced by chronic NO inhibition in utero in lambs and, thus, to investigate the potential role of impaired NO activity in the pathophysiology of PPHN. To determine the physiologic derangements caused by chronic NO inhibition in utero, the hemodynamic effects of a continuous 10-d infusion of N'O-nitro-0.9% saline alone (N'V-nitro-L-arginine vehicle) in utero were determined in newborn lambs over the first 3 h after birth. To determine whether chronic NO inhibition in utero affects the vascular anatomy, pulmonary vascular morphometric analysis was performed in these lambs at autopsy.
Methods

Surgical preparation
11 mixed-breed Western ewes (129.1±2.1 d ofgestation, term = 145 d) were operated on under sterile conditions with the use oflocal anesthesia (2% lidocaine hydrochloride), epidural anesthesia (4 ml of 1% tetracaine hydrochloride), and intravenous sedation (50-100 mg of ketamine hydrochloride). A polyvinyl catheter was inserted into the maternal pedal vein. Through a small uterine incision, the fetal hindlimb was exposed. Fetal anesthesia consisted of local anesthesia with 1% lidocaine hydrochloride and 20 mg ketamine hydrochloride i.m. Polyvinyl catheters were inserted into the fetal pedal artery and vein and were advanced to the descending aorta and the inferior vena cava, respectively. Through a second uterine incision, a left lateral thoracotomy was preformed in the fourth intercostal space. Succinylcholine hydrochloride (3-5 mg) was administrated intravenously to prevent fetal breathing movements. Polyvinyl catheters were then inserted into the internal thoracic artery and vein and advanced to the ascending aorta and right atrium, respectively. The pericardium was incised along the main pulmonary trunk. Three Teflon cannulae attached to polyvinyl catheters were then inserted, one into the proximal main pulmonary trunk, one into the main pulmonary artery distal to the ductus arteriosus, and one into the left atrium. An ultrasonic flow transducer (Transonic Systems, Ithaca, NY) was placed around the left pulmonary artery to measure left pulmonary arterial blood flow. An no. 8 French chest tube was placed in the pleural space. The thoracotomy incision was closed in layers. Warm saline was infused to replace the lost amniotic fluid and the uterine incision was closed. A polyvinyl catheter was placed in the amniotic cavity. The catheters were filled with heparin sodium, plugged, and brought to the skin along with the transducer cable, where they were protected in a pouch secured to the ewe's flank. After recovery from anesthesia, the ewe was returned to the cage. Antibiotics (2 million units ofpenicillin G procaine and 100 mg ofgentamicin sulfate) were administered intravenously to the ewe and into the amniotic cavity during surgery and daily thereafter. The chest tube was aspirated daily. All All measurements were then repeated and the other vasodilator was given. After recovery, the hemodynamic variables were measured and a continuous infusion ofN'O-nitro-L-arginine (0.3 mg/min) or its vehicle 0.9% saline (6 ml/h) was begun into the distal main pulmonary artery via an ambulatory infusion pump (Dakman, Buffalo, NY). The infusion solution was changed daily. The dose of Nw-nitro-L-arginine was chosen after preliminary stuides showed that a 24-h infusion did not change resting pulmonary or systemic arterial pressure, but completely blocked the pulmonary vasodilating effects of ACh (a vasodilator dependent upon endogenous NO production).
The fetal study was repeated at 140 d of gestation. After recovery, the pregnant ewe was given epidural anesthesia (4 ml of 1% tetracaine hydrochloride) and intravenous sedation (50-10 mg ketamine hydrochloride). Ketamine hydrochloride (20 mg) and succinylcholine hydrochloride (5 mg) were given to the fetus, which was then intubated with a 4.5-mm o.d. endotracheal tube. The lambs were delivered via cesarean section. Tracheal fluid was drained by gravity and Exosurf(IO ml) was instilled into the airway over 10 min to preclude the possibility of surfactant deficiency. The lamb was mechanically ventilated with a pediatric time-cycled pressure-limited ventilator (Healthdyne, Marietta, GA). The umbilical cord was clamped and ligated after initiation of mechanical ventilation. After delivery, the, ewe was given a lethal dose of pentobarbital sodium followed by bilateral thoracotomy.
Newborn study. The hemodynamic variables were monitored continuously throughout the 3-h study period, and measured at 15, 30, 45, 60, 120, and 180 min. Systemic arterial blood gases were obtained from the ascending and descending aorta every 15 min over the first hour, and every 30 min thereafter. Ventilation was adjusted to maintain normocarbic ventilation and a Pao2 > 50 torr. The lamb was anesthetized with a continuous infusion of ketamine hydrochloride (-1 mg/kg per min); normothermia was achieved with heating lamps. Sodium bicarbonate was given intermittently over the first 30 min to maintain a systemic arterial pH > 7.30. 0.9% saline was given intermittently to maintain atrial pressures > 2 mmHg. At 3 h, L-arginine (150 mg/kg) was infused intravenously over 5 min, and the hemodynamic variables and systemic arterial blood gases and pH were measured 15 min later, when a new steady state was achieved. The lamb was then given a lethal dose of pentobarbital sodium followed by bilateral thoracotomy. At autopsy, catheter placement was confirmed and closure of the ductus arteriosus was confirmed.
Pulmonary vascular morphology. The trachea and lungs were removed from the chest wall cavity through a midline sternotomy and frozen. They were later thawed by immersion in a 40°C water bath as previously described (27) . The pulmonary arteries were injected with a warm barium gelatin suspension (400 ml of micropaque powder [Nicholas Picker Co., Stoughton, MA], 50 g ofgelatin, Bloom 8-0 [Fisher Scientific Co., Fairlawn, NJ], 500 ml of distilled water, and a few crystals of phenol) at 75-cm water pressure and 60°C for 2 min using the technique of Reid adapted from the method of Short (28) . Next 
Statistical analysis
The means±standard deviation and standard error were calculated for the hemodynamic variables, systemic arterial blood gases, and pH during all experimental conditions. For the fetal study, the effects of each vasoactive stimulus (N'-nitro-L-arginine, 0.9% saline, ACh, SNP, and L-arginine) on these variables were compared to their previous steadystate condition by the paired t test. The effects ofeach vasoactive stimulus on pulmonary vascular resistance was compared to their previous steady-state condition by the Wilcoxin signed-rank test. The percent change in pulmonary arterial pressure and absolute change in pulmonary blood flow induced by these stimuli were compared between study groups by the unpaired t test. The percent change in pulmonary vascular resistance induced by these stimuli were compared between study groups by the Mann-Whitney U test.
For the newborn study, comparisons of these variables over time within each study group was made by ANOVA for repeated measures. Comparisons ofthese variables between study groups were made by the unpaired t test. Comparisons ofpulmonary vascular resistance between study groups were made by the Mann-Whitney U test.
The distribution of vessels by wall structure was compared by x2 analysis except for small cell frequencies where Fisher's exact test was used. A P < 0.05 was considered statistically significant.
Results
Fetal study. The baseline hemodynamic variables and systemic arterial blood gases and pH were similar between the two groups, and within the normal range for the laboratory.
Before beginning the infusion (NV-nitro-L-arginine or 0.9% saline), ACh decreased mean pulmonary arterial pressure, pulmonary vascular resistance, and mean systemic arterial pressure, and increased left pulmonary blood flow (Table I) . SNP produced similar hemodynamic effects, but did not increase left pulmonary blood flow (Fig. 1) .
The infusion of No-nitro-L-arginine or 0.9% saline did not change any of the hemodynamic variables. After the infusions, at 140 d of gestation, the baseline hemodynamic variables and systemic arterial blood gases and pH were similar between the two groups. After the Nw-nitro-L-arginine infusion, an injection ofACh did not change any ofthe hemodynamic variables; however, it continued to produce pulmonary vasodilation after the saline infusions (Table II ). An infusion of SNP decreased mean pulmonary arterial pressure and pulmonary vascular resistance similarly in the two groups. SNP induced a greater increase in left pulmonary blood flow in the lambs receiving N'w-nitro-L-arginine (Fig. 1) .
Newborn study. In the Nw-nitro-L-arginine-treated lambs, the mean pulmonary arterial pressure did not change from in utero values over the 1 80-min study period after birth. In contrast, the mean pulmonary arterial pressure decreased significantly in the saline-treated lambs over this period (Tables III  and IV , Fig. 2 ). In the Nw-nitro-L-arginine-treated lambs, the increase in left pulmonary blood flow and decrease in left pulmonary vascular resistance were substantially less than in the saline-treated lambs. The ratio of mean pulmonary arterial pressure to systemic arterial pressure decreased over the first 30 min in both groups oflambs (Fig. 3) . However, in the Nw-nitro-L-arginine-treated lambs, it increased back to in utero values (1.0); it continued to decrease to 0.55 in the saline-treated lambs. Systemic arterial Po2 increased after birth in both groups of lambs. There were no differences in ascending and descending aortic saturations. Two Nw-nitro-L-argininetreated lambs had hypoxemia (Pao2 < 45 torr) that was minimally responsive to oxygen therapy. Their mean pulmonary arterial pressure was equal to or intermittently greater than the mean systemic arterial pressure. These lambs had right to left atrial shunting demonstrated by echocardiography. 180 min after delivery, the mean pulmonary arterial pressure, left pulmonary vascular resistance, and the ratio of mean pulmonary arterial pressure to systemic arterial pressure were all higher, and left pulmonary blood flow was lower in the N'w-nitro-L-arginine-treated lambs as compared to the salinetreated lambs (P < 0.05). Systemic arterial pressure, heart rate, left and right atrial pressures, and systemic arterial blood gases and pH were similar between the groups.
The intravenous infusion ofL-arginine reversed the pulmo- (Fig. 4) . It also decreased mean systemic arterial pressure (from 54.8±10.6 to 48.4±7.5, P < 0.05). Heart rate, left and right atrial pressure, and systemic arterial blood gases and pH did not change. In the saline-treated lambs, the intravenous infusion of L-arginine did not change any of the hemodynamic variables. After the infusion of L-arginine, mean pulmonary arterial pressure, left pulmonary vascular resistance, and left pulmonary blood flow were similar between the 2 groups (Fig. 4) . There were no differences in birth weight (3.76±1.0 kg for Nw-nitro-L-arginine vs. 3.82±0.3 kg for saline), lung weight, sex distribution, amount ofsodium bicarbonate or volume administered, or mean airway pressure utilized. The Nw-nitro-L-arginine-treated lambs required a higher inspired oxygen concentration to maintain a Pao2> 50 torr (P < 0.05). At autopsy, the ductus arteriosus was closed in all lambs.
There were no differences in the proportion of muscularized pulmonary arteries at any level betweeen the two groups (Tables V and VI) . We report that chronic in utero inhibition ofNO in fetal lambs with administration ofL-arginine. This is the first animal prepareproduces the physiologic derangements of PPHN afterbirth. ration to produce the physiologic derangements of PPHN, Before delivery, the Nw-nitro-L-arginine-treated lambs had a without producing fetal pulmonary hypertension or the assoselective impairment of endothelium-derived NO-dependent ciated pulmonary vascular remodeling. These data implicate a pulmonary vasodilation; the pulmonary vasodilating effects of crucial role for NO activity in the transitional circulation, parACh did not occur, and the pulmonary vasodilating effects of ticularly in the period immediately after the initial rapid fall in SNP were normal. After birth, mean pulmonary arterial pres-pulmonary vascular resistance after birth. In addition, this sure did not decrease in the N'O-nitro-L-arginine-treated lambs, study suggests that in utero events resulting in endothelial dysand often exceeded systemic arterial pressure. Left pulmonary function and impairment ofNO activity may produce the physvascular resistance initially decreased after birth, but then iologic derangements of PPHN. tended to increase over the 3-h study period, becoming signifiTo study the effects of nitric oxide inhibition in utero, NWcantly greater than control lambs 30 min after birth. Similarly, nitro-L-arginine was continuously infused for 10 d. N"-nitro-Lleft pulmonary blood flow initially increased after birth, but arginine is an analogue of L-arginine, with a chemically altered then tended to decrease becoming significantly lower than conguanidino moiety. Nitric oxide is synthesized from L-arginine by the oxidation of a guanidino-nitrogen moiety of L-arginine (13) . Both in vitro and in vivo, NV-nitro-L-arginine produces a competitive and stereospecific inhibition of this oxidation (14, 27) . The dose of Nw-nitro-L-arginine was chosen after several preliminary studies showed that an infusion of0.3 mg/min did not change baseline fetal hemodynamics, and completely blocked the pulmonary vasodilating response of acetylcholine (a vasodilator dependent upon endogenous NO production) after 24 h. This ensured that our findings were independent of chronic fetal hypertension (a known animal model of PPHN), and that NO inhibition was achieved quickly. To ensure selective nitric oxide inhibition, the response of SNP (a vasodilator which releases its own NO) was also evaluated (17) . After the 1O-d infusion of No-nitro-L-arginine, the response of ACh was blocked, but the response to SNP was not. In fact, the increase in left pulmonary blood flow in response to sodium nitroprusside was augmented in the lambs receiving N'o-nitro-L-arginine.
This most likely represents an enhanced sensitivity of soluble guanylate cyclase to nitrovasodilators after chronic NO inhibition, which has been previously reported (30, 31) . Basal NO release is important in maintaining the resting pulmonary vascular tone ofthe fetus and newborn lamb; however, the role of NO release during the transitional circulation remains unclear (14) (15) (16) . In a previous study by Abman et al. (15) , Nw-nitro-L-arginine (1 mg/min) was infused for 30 min into the pulmonary artery oflate gestation fetal sheep immediately before cesarean-section delivery. This acute inhibition of NO attenuated the normal increase in pulmonary blood flow at birth, suggesting that nitric oxide activity contributes to the decrease in pulmonary vascular resistance at birth. However, the dose ofNw-nitro-L-arginine used increased baseline pulmonary arterial pressure and pulmonary vascular resistance. In addition, the decrease in pulmonary arterial pressure was not attenuated after birth. In the present study, the low dose of No-nitro-L-arginine used (0.3 mg/min) did not increase baseline pulmonary arterial pressure or pulmonary vascular resistance, but completely blocked the decrease in pulmonary arterial pressure, and attenuated the decrease in pulmonary vascular resistance after birth. Therefore, this study clearly defines the crucial role of NO activity in the transition of the pulmonary circulation at birth.
In the previous study by Abman et al. (15) , acute NO inhibition did not alter the immediate decrease in pulmonary vascular resistance that occurs within the first minute after birth, but attenuated the further decrease over the subsequent 60 min. In the present study, the immediate decrease in pulmonary vascular resistance and increase in pulmonary blood flow was not inhibited by chronic Nw-nitro-L-arginine infusions (Fig. 2) . However, 30 min later, differences in pulmonary vascular resistance and pulmonary blood flow appeared between the two groups and persisted for the 3-h study period. Increased blood flow and the associated increased shear stress are potent stimuli of nitric oxide release (32-34). This study suggests that, after an initial NO-independent decrease in pulmonary vascular resistance, the resultant increase in pulmonary blood flow stimulates NO release, which is critical in maintaining the further decrease in pulmonary vascular resistance after birth. Whether mechanical factors, the creation of an air-fluid interface, or changes in other vasoactive substances are responsible for the immediate decrease in pulmonary vascular resistance remains unclear. Leffler et al. (5) found that cyclooxygenase inhibition also did not alter the immediate decrease in pulmonary vascular resistance at birth, but attenuated the further decrease over the subsequent 10-20 min. This study did not investigate the relative roles of prostaglandins and NO in maintaining pulmonary vasodilation after birth. However, cyclooxygenase inhibition alone does not produce persistent elevation of pulmonary arterial pressure or decrease in pulmonary blood flow after birth (5, 35) .
Previous animal preparations have reproduced the physiologic and pathologic derangements ofpersistent pulmonary hypertension. These preparations include pharmacological or mechanical constriction or occlusion of the ductus arteriosus (26) (27) (28) (29) . Although the models are varied, they all produced chronic fetal pulmonary hypertension. Chronic fetal hypoxemia has not reliably reproduced either the physiologic or pathologic derangements of persistent pulmonary hypertension (36, 37) . This is the first animal preparation that reproduces the physiologic derangements of persistent pulmonary hypertension, without producing pulmonary vascular structural remodeling. In addition, this is the first animal preparation that reproduces the physiologic derangements ofpersistent pulmonary hypertension without producing chronic fetal pulmonary hypertension, suggesting another etiology for PPHN, i.e., NO inhibition.
In vitro, NO inhibits smooth muscle cell mitogenesis and proliferation (19) . However, in the present study, chronic NO In previous studies, acute NO inhibition did not reproduce persistent pulmonary hypertension (15) . We also performed several preliminary investigations which showed that No-nitro-L-arginine infusions of < 7 d in duration did not reproduce persistent pulmonary hypertension. Therefore, the chronic NInitro-L-arginine infusions utilized in this study most likely produce a more complete inhibition of NO synthesis, which is responsible for the persistent pulmonary hypertension.
Previous studies have shown that Nw-nitro-L-arginine induces NO inhibition by competitively inhibiting the oxidation ofL-arginine to L-citrulline, and that excess L-arginine administration can overcome this inhibition (14, 27 ). 3 h after delivery, an intravenous infusion of L-arginine completely reversed the physiologic derangements in our model. This finding, in a setting of normal pulmonary vascular morphology, strongly suggests that the physiologic derangements were produced purely by nitric oxide inhibition, and are reversible with initiation of NO production. Because NO inhibition was produced by NOnitro-L-arginine in this model, L-arginine will overcome the competitive inhibition and restore NO production. However, this does not imply that L-arginine will improve the physiologic derangements of infants with PPHN. For example, if vascular injury results in inability to produce or respond to NO, L-arginine administration will have no effect.
In summary, we found that chronic NO inhibition induced by the continuous infusion of N"-nitro-L-arginine in utero reproduced the physiologic derangements of persistent pulmonary hypertension after birth. Over the 3-h study period after birth, these lambs had persistent elevation of pulmonary arterial pressure which often exceeded systemic arterial pressure, elevated pulmonary vascular resistance, and decreased pulmonary blood flow. These derangements were obtained without pulmonary vascular remodeling and were completely reversed after reversal of NO inhibition with administration of L-arginine. This study establishes the important role of NO activity during the transitional circulation from fetal to newborn life, and provides a link between NO inhibition and the pathophysiology of PPHN. We speculate that in utero events resulting in endothelial dysfunction and NO inhibition may produce the physiologic derangements of PPHN.
